The remaining patient, who obtained an unsaturated test line result in the screening test, presented anti-tTG-IgA titers of 60.8 U/mL, anti-EMA 1/20, and a biopsy classified as Marsh 0-I; thus, it will be followed up for a definitive CD diagnosis. This evidence concerns the gene CD79A and Cowden disease.